Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics | 21 | 3 | 3 | 2 | €2.38 | €8.35 | 251.347% |
| Esperion Therapeutis.Inc. | 17 | 2 | 3 | 2 | €2.42 | €8.39 | 247.111% |
| Incyte Corp. | 12 | 3 | 0 | 1 | €56.00 | €78.05 | 39.369% |
| PTC Therapeutics Inc. | 16 | 9 | 2 | 1 | €28.80 | €41.81 | 45.188% |
| Novavax Inc. | 4 | 1 | 0 | 1 | €10.87 | €17.59 | 61.811% |
| Insmed Inc. | 40 | 1 | 11 | 1 | €64.50 | €70.13 | 8.721% |
| Agios Pharmaceuticals Inc. | 8 | 1 | 1 | 1 | €38.20 | €43.87 | 14.840% |
| Ardelyx Inc. | 2 | 1 | 1 | 1 | €5.17 | €11.00 | 112.684% |
| Gilead Sciences Inc | 23 | 1 | 12 | 0 | €62.14 | €75.00 | 20.695% |
| Regeneron Pharmaceuticals Inc. | 51 | 1 | 14 | 0 | €975.00 | €1,049.8 | 7.668% |
| Amgen Inc. | 34 | 0 | 11 | 0 | €289.30 | €305.58 | 5.626% |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 11 | 0 | €450.20 | €459.80 | 2.132% |
| Biogen Inc. | 58 | 1 | 8 | 0 | €210.50 | €291.35 | 38.406% |
| Eli Lilly Corp. | 79 | 0 | 30 | 0 | €860.50 | €900.00 | 4.590% |
| Corcept Therapeutics Inc. | 15 | 0 | 2 | 0 | €27.01 | €36.17 | 33.929% |
| Nektar Therapeutics | 4 | 1 | 1 | 0 | €1.17 | €2.40 | 104.604% |
| Pfizer Inc. | 37 | 4 | 10 | 0 | €25.60 | €40.00 | 56.250% |
| Exact Sciences | 20 | 0 | 6 | 0 | €40.58 | €74.22 | 82.930% |
| Acadia Pharmaceuticals | 30 | 1 | 2 | 0 | €15.56 | €31.00 | 99.315% |
| Rigel Pharmaceutical Inc. | 14 | 0 | 3 | 0 | €0.74 | €13.82 | 1767.203% |